Terms: = Head and neck cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Clinical Outcome
42 results:
1. Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S; Remick J; McDonald M; Abousaud M; Tan AC; Fadlullah MZH; Chaudhary R; Muzaffar J; Kirtane K; Liu Y; Chen GZ; Shin DM; Teng Y; Chung CH
Nat Med; 2023 Apr; 29(4):880-887. PubMed ID: 37012550
[TBL] [Abstract] [Full Text] [Related]
2. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
[TBL] [Abstract] [Full Text] [Related]
3. Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With head and neck cancer.
Singh A; Kitpanit S; Neal B; Yorke E; White C; Yom SK; Randazzo JD; Wong RJ; Huryn JM; Tsai CJ; Zakeri K; Lee NY; Estilo CL
JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):151-159. PubMed ID: 36547968
[TBL] [Abstract] [Full Text] [Related]
4. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study.
Lehrich BM; Goshtasbi K; Hsu FPK; Kuan EC
Childs Nerv Syst; 2021 May; 37(5):1535-1545. PubMed ID: 33641032
[TBL] [Abstract] [Full Text] [Related]
6. Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040).
Pai SI; Faivre S; Licitra L; Machiels JP; Vermorken JB; Bruzzi P; Gruenwald V; Giglio RE; Leemans CR; Seiwert TY; Soulieres D
J Immunother Cancer; 2019 Apr; 7(1):96. PubMed ID: 30944020
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
[No Abstract] [Full Text] [Related]
8. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract] [Full Text] [Related]
9. Fractionated dosage of radioiodine for the ablation of low-risk differentiated thyroid cancer has no impact on survival.
Woliński K; Czepczyński R; Stangierski A; Trojanowski M; Rewaj-Łosyk M; Ziemnicka K; Bączyk M; Dyzmann-Sroka A; Ruchała M
Endokrynol Pol; 2018; 69(3):230-234. PubMed ID: 29504625
[TBL] [Abstract] [Full Text] [Related]
10. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.
Shang A; Lu WY; Yang M; Zhou C; Zhang H; Cai ZX; Wang WW; Wang WX; Wu GQ
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1754-1762. PubMed ID: 29073835
[TBL] [Abstract] [Full Text] [Related]
11. Association of Oral Cavity and Oropharyngeal cancer Biomarkers in Surgical Drain Fluid With Patient outcomes.
Lassig AAD; Joseph AM; Lindgren BR; Yueh B
JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):670-678. PubMed ID: 28418447
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract] [Full Text] [Related]
14. clinical outcome and health-related quality-of-life following microsurgical reconstruction in patients with oral and oropharyngeal cancer.
Al-Hayder S; Elberg JJ; Charabi B
Acta Otolaryngol; 2017 May; 137(5):541-545. PubMed ID: 27809693
[TBL] [Abstract] [Full Text] [Related]
15. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
[TBL] [Abstract] [Full Text] [Related]
16. The use of immunohistochemistry in detection of perineural invasion in mucoepidermoid carcinoma.
Lanzel E; Robinson RA; Zimmerman MB; Pourian A; Hellstein JW
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun; 121(6):636-42. PubMed ID: 27068680
[TBL] [Abstract] [Full Text] [Related]
17. External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Petersen JB; Primdahl H; Johansen J
Acta Oncol; 2015; 54(9):1301-9. PubMed ID: 26248025
[TBL] [Abstract] [Full Text] [Related]
18. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal cancer: Is It a Viable Therapeutic Option?
Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
[TBL] [Abstract] [Full Text] [Related]
19. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract] [Full Text] [Related]
20. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
Raju SC; Hauff SJ; Lemieux AJ; Orosco RK; Gross AM; Nguyen LT; Savariar E; Moss W; Whitney M; Cohen EE; Lippman SM; Tsien RY; Ideker T; Advani SJ; Nguyen QT
Oral Oncol; 2015 May; 51(5):470-5. PubMed ID: 25735654
[TBL] [Abstract] [Full Text] [Related]
[Next]
